<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001668085</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001858848</issuerCik>
      <issuerName>Tenaya Therapeutics, Inc.</issuerName>
      <secFileNumber>001-40656</secFileNumber>
      <issuerAddress>
        <com:street1>171 OYSTER POINT BLVD., SUITE 500</com:street1>
        <com:city>SOUTH SAN FRANCISCO</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94080</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>415-865-2066</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>COLUMN GROUP III-A, LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>BTIG, LLC</name>
        <address>
          <com:street1>350 Bush Street, 9th floor</com:street1>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94104</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>1060727</noOfUnitsSold>
      <aggregateMarketValue>596552.86</aggregateMarketValue>
      <noOfUnitsOutstanding>213744535</noOfUnitsOutstanding>
      <approxSaleDate>02/25/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ GS</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>08/30/2019</acquiredDate>
      <natureOfAcquisitionTransaction>Series B financing</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Tenaya Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>177927</amountOfSecuritiesAcquired>
      <paymentDate>08/30/2019</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>12/20/2018</acquiredDate>
      <natureOfAcquisitionTransaction>Series A financing</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Tenaya Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>313640</amountOfSecuritiesAcquired>
      <paymentDate>12/20/2018</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>03/30/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Series B financing</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Tenaya Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>177927</amountOfSecuritiesAcquired>
      <paymentDate>03/30/2020</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>08/25/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Series B financing</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Tenaya Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>177927</amountOfSecuritiesAcquired>
      <paymentDate>08/25/2020</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common	</securitiesClassTitle>
      <acquiredDate>12/17/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Series B financing</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Tenaya Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>213306</amountOfSecuritiesAcquired>
      <paymentDate>12/17/2020</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>COLUMN GROUP III-A, LP</name>
        <address>
          <com:street1>1 Letterman Drive</com:street1>
          <com:street2>Suite DM-900</com:street2>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94129</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>02/10/2026</saleDate>
      <amountOfSecuritiesSold>182295</amountOfSecuritiesSold>
      <grossProceeds>148770.95</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>COLUMN GROUP III-A, LP</name>
        <address>
          <com:street1>1 Letterman Drive, Suite DM-900</com:street1>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94129</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>02/11/2026</saleDate>
      <amountOfSecuritiesSold>2151458</amountOfSecuritiesSold>
      <grossProceeds>1464712.61</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>COLUMN GROUP III-A, LP</name>
        <address>
          <com:street1>1 Letterman Drive, Suite DM-900</com:street1>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94129</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>02/20/2026</saleDate>
      <amountOfSecuritiesSold>277769</amountOfSecuritiesSold>
      <grossProceeds>170800.16</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>COLUMN GROUP III-A, LP </name>
        <address>
          <com:street1>1 Letterman Drive, Suite DM-900</com:street1>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94129</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>02/23/2026</saleDate>
      <amountOfSecuritiesSold>162291</amountOfSecuritiesSold>
      <grossProceeds>96920.19</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>COLUMN GROUP III-A, LP</name>
        <address>
          <com:street1>1 Letterman Drive, Suite DM-900</com:street1>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94129</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>02/24/2026</saleDate>
      <amountOfSecuritiesSold>349212</amountOfSecuritiesSold>
      <grossProceeds>214870.14</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>02/25/2026</noticeDate>
      <signature>James Evangelista</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
